國立虎尾科技大學 |

Gold and its Complexes in Anticancer Chemotherapy

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Gold and its Complexes in Anticancer Chemotherapy/ by Mohmmad Younus Wani, Manzoor Ahmad Malik.
作者:	Wani, Mohmmad Younus.
其他作者:	Malik, Manzoor Ahmad.
面頁冊數:	IX, 173 p. 124 illus., 29 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-981-33-6314-4
ISBN:	9789813363144

Gold and its Complexes in Anticancer Chemotherapy
Wani, Mohmmad Younus.

Gold and its Complexes in Anticancer Chemotherapy[electronic resource] /by Mohmmad Younus Wani, Manzoor Ahmad Malik. - 1st ed. 2021. - IX, 173 p. 124 illus., 29 illus. in color.online resource.

Chapter 1. Cancer -- Chapter 2. Types of cancer -- Chapter 3. Classification -- Chapter 4. Cancer or tumor nomenclature -- Chapter 5. Heterogeneity -- Chapter 6. Invasion and metastasis -- Chapter 7. How cancer arises? -- Chapter 8. Epidemiology -- Chapter 9. Economic burden -- Chapter 10. Treatment modalities -- Chapter 11. Chemotherapy -- Chapter 12. Properties of metals and metal complexes -- Chapter 13. Platinum based anticancer agents -- Chapter 14. Chemistry of cisplatin -- Chapter 15. Mechanism of action of platinum drugs -- Chapter 16. Non-platinum anticancer agents -- Chapter 17. Chemistry of gold -- Chapter 18. Gold and its complexes in medicine -- Chapter 19. Auranofin and its analogues -- Chapter 20. Classes of gold complexes -- Chapter 21. Mechanisms of action of anticancer gold complexes -- Chapter 22. Perspectives.

This book presents an overview of cancer and the genesis, and development of different treatment strategies and modalities against cancer. The emergence of gold and its complexes as promising anticancer chemotherapeutic agents have the potential to substitute or replace the platinum based chemotherapeutic agents. Gold complexes have demonstrated considerable anti-proliferative properties, chiefly attributed to their anti-mitochondrial effects, they make gold complexes excellent candidates as anti-cancer agents compared to their platinum-based counterparts. This book provides a critical review of recent advances made in the development of gold complexes as anti-cancer agents. In this context, it examines a number of different ligand architectures, provides comprehensive information on gold complexes’ mechanism of action and toxicity issues and, in closing, outlines future research directions.

ISBN: 9789813363144

Standard No.: 10.1007/978-981-33-6314-4doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM1-950

Dewey Class. No.: 615

Gold and its Complexes in Anticancer Chemotherapy
LDR:03119nam a22003975i 4500 001 1053182
003 DE-He213
005 20210618200432.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789813363144 $9 978-981-33-6314-4
024 7 $a 10.1007/978-981-33-6314-4 $2 doi
035 $a 978-981-33-6314-4
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
100 1 $a Wani, Mohmmad Younus. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1358000
245 1 0 $a Gold and its Complexes in Anticancer Chemotherapy $h [electronic resource] / $c by Mohmmad Younus Wani, Manzoor Ahmad Malik.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a IX, 173 p. 124 illus., 29 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Cancer -- Chapter 2. Types of cancer -- Chapter 3. Classification -- Chapter 4. Cancer or tumor nomenclature -- Chapter 5. Heterogeneity -- Chapter 6. Invasion and metastasis -- Chapter 7. How cancer arises? -- Chapter 8. Epidemiology -- Chapter 9. Economic burden -- Chapter 10. Treatment modalities -- Chapter 11. Chemotherapy -- Chapter 12. Properties of metals and metal complexes -- Chapter 13. Platinum based anticancer agents -- Chapter 14. Chemistry of cisplatin -- Chapter 15. Mechanism of action of platinum drugs -- Chapter 16. Non-platinum anticancer agents -- Chapter 17. Chemistry of gold -- Chapter 18. Gold and its complexes in medicine -- Chapter 19. Auranofin and its analogues -- Chapter 20. Classes of gold complexes -- Chapter 21. Mechanisms of action of anticancer gold complexes -- Chapter 22. Perspectives.
520 $a This book presents an overview of cancer and the genesis, and development of different treatment strategies and modalities against cancer. The emergence of gold and its complexes as promising anticancer chemotherapeutic agents have the potential to substitute or replace the platinum based chemotherapeutic agents. Gold complexes have demonstrated considerable anti-proliferative properties, chiefly attributed to their anti-mitochondrial effects, they make gold complexes excellent candidates as anti-cancer agents compared to their platinum-based counterparts. This book provides a critical review of recent advances made in the development of gold complexes as anti-cancer agents. In this context, it examines a number of different ligand architectures, provides comprehensive information on gold complexes’ mechanism of action and toxicity issues and, in closing, outlines future research directions.
650 0 $a Pharmacology. $3 583819
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Cancer research. $3 1253664
650 0 $a Nanotechnology. $3 557660
650 0 $a Pharmacy. $3 582411
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Nanotechnology and Microengineering. $3 722030
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
700 1 $a Malik, Manzoor Ahmad. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1358001
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789813363137
776 0 8 $i Printed edition: $z 9789813363151
776 0 8 $i Printed edition: $z 9789813363168
856 4 0 $u https://doi.org/10.1007/978-981-33-6314-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)